Mark J. Suto

Mark J. Suto

Corporate Officer/Principal presso Southern Research Institute

Health Technology
Commercial Services
Consumer Services

Profilo

Mark J.
Suto
currently works at American Chemical Society, as Member and Southern Research Institute, as Vice President-Drug Discovery Division from 2011.
Dr. Suto also formerly worked at DuPont Pharmaceuticals Co., as Executive Director-Chemistry from 1999 to 2002, Neusentis, Inc., as Vice President-Chemical & Pharmaceutical Sciences from 2009 to 2011, Neurion Pharmaceuticals, Inc., as Chief Scientific Officer & EVP in 2002, Deltagen Research Laboratories LLC, as Vice President-Chemical & Biological Sciences, and Parke-Davis Pharmaceutical Research, Inc., as Principal.
Dr. Suto received his undergraduate degree and doctorate degree from The State University of New York.

Posizioni attive di Mark J. Suto

SocietàPosizioneInizio
Corporate Officer/Principal 18/08/2011
Corporate Officer/Principal -
Tutte le posizioni attive di Mark J. Suto

Precedenti posizioni note di Mark J. Suto

SocietàPosizioneFine
Corporate Officer/Principal 01/08/2011
Corporate Officer/Principal 01/01/2002
Direttore Tecnico/Scientifico/R&S 01/01/2002
Parke-Davis Pharmaceutical Research, Inc. Corporate Officer/Principal -
Deltagen Research Laboratories LLC Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Mark J. Suto

Formazione di Mark J. Suto

The State University of New York Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mark J. Suto

Relazioni

100 +

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private7

Health Technology

Deltagen Research Laboratories LLC

Health Technology

Commercial Services

Health Technology

Parke-Davis Pharmaceutical Research, Inc.

Commercial Services

Vedi le connessioni aziendali
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA